Molecular profiling of a 6-hydroxydopamine model of Parkinson's disease.
Convection enhanced delivery of 6-hydroxydopamine (6-OHDA) to the rat striatum results in a model of Parkinson's disease. An important feature of this unilateral model is the progressive loss of dopaminergic (DA) neurons over the course of several weeks. To improve the understanding of this model, gene expression changes in the substantia nigra, which contains the DA neuron cell bodies, and the striatum, which contains the DA neuron synaptic terminals, were examined using DNA microarrays. Samples were collected and behavior was analyzed from vehicle and toxin treated animals at 3 days, 1 week, 2 weeks and 4 weeks following 6-OHDA treatment. Tissue DA content was determined and samples from animals which exhibited a substantial depletion of striatal DA were included in the subsequent gene expression analysis. The results of the gene expression analysis indicated that 6-OHDA elicits a vigorous inflammatory response, comprised of several distinct pathways, in the striatum at the earliest time point tested. In contrast, relatively few gene expression changes were observed in the SN at the 3-day time point. In both tissues examined there was evidence for a vigorous inflammatory response at the 1- and 2-week time points, which was substantially diminished by the 4-week time point. Inflammation plays a prominent role in the 6-OHDA model of Parkinson's disease.
Na
Sang J
SJ
Department of Stroke, Merck Research Laboratories, P.O. Box 4, WP26A-2000, West Point, PA 19486-0004, USA. sangjin_na@merck.com
DiLella
Anthony G
AG
Lis
Edward V
EV
Jones
Keith
K
Levine
David M
DM
Stone
David J
DJ
Hess
J F
JF
D000818:Animals; D003342:Corpus Striatum / Q000378:metabolism*; D004195:Disease Models, Animal; D004298:Dopamine / Q000378:metabolism*; D020869:Gene Expression Profiling; D007249:Inflammation / Q000139:chemically induced; D008297:Male; D020411:Oligonucleotide Array Sequence Analysis; D016627:Oxidopamine / Q000008:administration & dosage; D010300:Parkinson Disease / Q000209:etiology / Q000378:metabolism* / Q000473:pathology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013378:Substantia Nigra / Q000378:metabolism*
D016627:Oxidopamine; D004298:Dopamine